Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Novel sulfamoylamino-containing cephalosporin derivatives, and their in vitro antibacterial properties

Xudong Jiang1, Li Chen1, Xiaoling Lu1,2 , Lan Liao1, WeiGuang Wang1, Xiaocheng Huang2

1School of Medicine, Guangxi University of Science and Technology; 2College of Biological and Chemical Engineering, Guangxi University of Science and Technology, Liuzhou 545005, China.

For correspondence:-  Xiaoling Lu   Email: v0964y@163.com

Accepted: 28 November 2019        Published: 31 December 2019

Citation: Jiang X, Chen L, Lu X, Liao L, Wang W, Huang X. Novel sulfamoylamino-containing cephalosporin derivatives, and their in vitro antibacterial properties. Trop J Pharm Res 2019; 18(12):2617-2621 doi: 10.4314/tjpr.v18i12.22

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To prepare and develop new antibacterial agents with novel molecular structures.
Method: A series of novel sulfamoylamino-containing cephalosporin derivatives were synthesized. The in vitro antibacterial effects of the derivatives against Gram-positive bacteria (S. aureus, S. pneumonia and S. epidermidis), and Gram-negative bacteria (E. coli, P. aeruginosa, and K. pneumonia) were investigated.
Results: Compounds 13a and 13b exhibited excellent antibacterial effects against all the Gram-positive and Gram-negative bacteria tested, when compared with other cephalosporin derivatives.
Conclusion: Of these new cephalosporin derivatives, compounds 13a and 13b show the most potent antibacterial activity and would need to be further investigated.

Keywords: Cephalosporin, Sulfamoylamino derivatives, Gram-positive, Gram-negative, Antibacterial

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates